Choquet H, Yin J, Jacobson AS, Horton BH, Hoffmann TJ, Jorgenson E, Avins AL, Pressman AR, Commun Biol.4(1):864. doi: 10.1038/s42003-021-02356-y., 2021 Jul 22
Associated Topics
Related Publications
Treatment of refractory chronic demyelinating polyneuropathy with lymphoid irradiation.
Rosenberg NL, Lacy JR, Kennaugh RC, Holers VM, Neville HE, Kotzin BL.
Muscle Nerve. 8(3):223-32.
1985 Mar 01
Muscle Nerve. 8(3):223-32.
1985 Mar 01
Interferon beta-1a in children with multiple sclerosis is well tolerated.
Waubant E, Hietpas J, Stewart T, Dyme Z, Herbert J, Lacy J, Miller C, Rensel M, Schwid S, Goodkin D.
Neuropediatrics. 32(4):211-3.
2001 Aug 01
Neuropediatrics. 32(4):211-3.
2001 Aug 01
Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling.
Kantor AB, Deng J, Waubant E, Lin H, Becker CH, Lacy JR, Perrone AM, Bennett D, Goelz SE.
J Neuroimmunol. 188(1-2):103-16. Epub 2007 Jul 5.
2007 Aug 01
J Neuroimmunol. 188(1-2):103-16. Epub 2007 Jul 5.
2007 Aug 01
Patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system.
Romanelli RJ, Shah SN, Ikeda L, Lynch B, Craig TL, Cappelleri JC, Jukes T, Ishisaka D.
Am J Manag Care. 23(2):e50-e56.
2017 Feb 01
Am J Manag Care. 23(2):e50-e56.
2017 Feb 01
Analyses of nursing home residents with multiple sclerosis and depression using the Minimum Data Set.
Buchanan RJ, Wang S, Tai-Seale M, Ju H.
Mult Scler. 9(2):171-88.
2003 Mar 01
Mult Scler. 9(2):171-88.
2003 Mar 01